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nNOS and coronary flow during mental stress 
ABSTRACT 23 
Introduction. Mental stress-induced ischemia approximately doubles the risk of cardiac 24 
events in patients with coronary artery disease, yet the mechanisms underlying changes in 25 
coronary blood flow in response to mental stress are poorly characterized. Neuronal nitric 26 
oxide synthase (nNOS) regulates basal coronary blood flow in healthy humans and mediates 27 
mental stress-induced vasodilation in the forearm. However, its possible role in mental-stress-28 
induced increases in coronary blood flow is unknown. Methods. We studied eleven patients (6 29 
men, mean age 58±14 years) undergoing elective diagnostic cardiac catheterization, and 30 
assessed the vasodilator response to mental stress elicited by the Stroop color-word test.  31 
Intra-coronary substance P (20pmol/min) and isosorbide dinitrate (1mg) were used to assess 32 
endothelium-dependent and -independent vasodilation respectively.  Coronary blood flow 33 
was estimated using intra-coronary Doppler recordings and quantitative coronary 34 
angiography to measure coronary artery diameter. Results. Mental stress increased coronary 35 
flow by 34±7.0% over the preceding baseline during saline infusion (p<0.01), and this was 36 
reduced to 26±7.0% in the presence of the selective nNOS inhibitor S-methyl L-thiocitrulline 37 
(SMTC, 0.625µmol/min; p<0.001). Mental stress increased coronary artery diameter by 38 
6.9±3.7% (p=0.02), and by 0.5±2.8% (p=0.51) in the presence of SMTC. The response to 39 
substance P did not predict the response to mental stress (r2 = -0.22, p=0.83). Conclusion. 40 
nNOS mediates the human coronary vasodilator response to mental stress, predominantly 41 
through actions at the level of coronary resistance vessels. 42 
 43 
Keywords: mental stress, coronary, endothelial function, nitric oxide, human 44 
 45 
New and Noteworthy: Acute mental stress induces vasodilation of the coronary 46 
microvasculature. Here, we show that this response involves neuronal nitric oxide synthase 47 






Acute mental stress can impact on cardiovascular morbidity and mortality, triggering 52 
myocardial infarction, ventricular arrhythmia and left ventricular failure (11). Analogous to 53 
exercise-induced stress, mental stress can exert detrimental effects due to sub-optimal 54 
coupling between myocardial oxygen demand and blood flow (31). The physiological 55 
cardiovascular response to mental stress mirrors that to other sympathetic stimuli and includes 56 
a catecholamine-driven increase in heart rate, blood pressure and cardiac contractility (17). 57 
Coronary blood flow increases in parallel to the higher myocardial oxygen demand, mediated 58 
mainly by reduction in coronary vascular resistance. Factors identified to mediate coronary 59 
vasodilator reserve include KCa channels (27), adenosine and nitric oxide (NO) (45). The 60 
vasomotor response to mental stress can be attenuated or even reversed in the presence of 61 
coronary artery disease; a condition that features endothelial dysfunction and reduced NO 62 
availability (9, 41, 43).  63 
Until relatively recently, it was generally assumed that the NO responsible for 64 
mediating local increases in blood flow was generated by endothelial NO synthase (eNOS) 65 
expressed in endothelial cells (10, 16). However, studies using intra-arterial infusion of a 66 
selective neuronal NOS (nNOS) inhibitor show that local nNOS-derived NO is a major 67 
contributor to the basal regulation of microvascular tone and blood flow in the human forearm 68 
and coronary circulations (32, 33). It was also found that local nNOS is involved in mental 69 
stress-induced forearm vasodilatation in healthy humans. In this study, we have investigated 70 
the role of nNOS in the changes in coronary blood flow during acute mental stress in humans.  71 
 72 
METHODS 73 
The study was conducted in accordance with the Declaration of Helsinki and received 74 
ethical approval from the local Research and Ethics Committee. All participants provided 75 
written informed consent. Eleven patients (6 men, mean age 58±14 years) undergoing elective 76 
diagnostic coronary angiography at King’s College Hospital, London were included in the 77 
nNOS and coronary flow during mental stress 
study. Patients had to have at least one angiographically unobstructed coronary artery as the 78 
study vessel. Those with a history of coronary disease, myocardial infarction, left ventricular 79 
impairment, dysrhythmia or renal impairment were excluded. Participants abstained from 80 
food for at least 6 hours prior to cardiac catheterization, and from all medication (except 81 
aspirin) on the day of the procedure. 82 
 Standard diagnostic coronary angiography was performed in a quiet, temperature-83 
controlled cardiac catheterization laboratory with digital cineangiography. After completion 84 
of the diagnostic procedure, a 6F guide catheter was positioned in the study artery and a 85 
0.014-inch intra-coronary Doppler wire (FloWire, Volcano Therapeutics, Rancho Cordova, 86 
CA) was advanced into a proximal segment that was free from side branches. The Doppler 87 
wire was interfaced with a real-time spectral analysis system (ComboMap Pressure and Flow 88 
system; Volcano Therapeutics) to record the average peak velocity (APV) of blood flow. 89 
APV recordings were taken prior to coronary angiography at each stage of the protocol, 90 
which was performed using non-ionic contrast medium (Omnipaque, GE Healthcare, Inc) and 91 
without altering the angle of projection during the study. Offline analysis was performed 92 
using an automated quantitative coronary edge detection system (Philips) to measure changes 93 
in epicardial coronary artery diameter in a 2.5 to 5mm length segment of vessel, ~2.5mm 94 
distal to the tip of the Doppler wire. Coronary flow was derived from the APV and arterial 95 
diameter (12). 96 
 All drugs were infused via the guide catheter into the study artery at a rate of 97 
2ml/min. The selective nNOS inhibitor S-methyl L-thiocitrulline (SMTC) was obtained from 98 
Merck Millipore (Massachusetts, USA) and was prepared to Good Medical Practice standards 99 
for human use in a nationally accredited pharmaceutical manufacturing facility. Substance P 100 
was obtained from Bachem (Bubendorf, Switzerland) and isosorbide dinitrate (ISDN) from 101 
Schwarz Pharma (Watford, UK).  102 
A schematic representation of the protocol is shown in Figure 1. Measurements 103 
began once a steady baseline was achieved during intracoronary infusion of 0.9% saline. 104 
Substance P was then infused for 2 minutes at 20pmol/min, a dose that elicits eNOS-mediated 105 
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endothelium-dependent vasodilation without inducing systemic effects (24). Following a 106 
washout period with normal saline, a 1mg ISDN bolus was administered to assess 107 
endothelium-independent vasodilatation (32). After a further saline washout, the Stroop color-108 
word test was performed to elicit mental stress (15). This was followed by a recovery period 109 
after which SMTC (0.625µmol/min) was infused for 7 min. This dose of SMTC has 110 
previously been shown to provide selective inhibition of nNOS in the coronary circulation in 111 
a similar patient population (32). SMTC infusion was continued while the Stroop test was 112 
repeated. In 2 patients, a second Stroop test was performed during saline instead of SMTC 113 
infusion, in order to confirm that it evoked a reproducible increase in blood flow. Aortic 114 
pressure, heart rate and APV were recorded at baseline and after each phase of the protocol 115 
and coronary angiography was performed to quantify coronary diameter. The ECG was 116 
continuously monitored. 117 
 Statistical analyses. Subject characteristics are summarized as mean ± SD; other 118 
results are presented as mean ± SEM. Vasodilator/constrictor responses were analyzed both 119 
as absolute change in coronary flow and as percentage change from the immediately 120 
preceding baseline. Responses were compared by analysis of variance for repeated measures 121 
with adjustment for baseline values of coronary blood flow where appropriate (ANOVA / 122 
ANCOVA). Bonferroni correction for multiple comparisons was applied. All tests were 2-123 
tailed and differences were considered significant at p<0.05.  124 
  125 
RESULTS 126 
Baseline subject characteristics are shown in Table 1. The indications for coronary 127 
angiography included chest pain (7 subjects), dyspnea (2 subjects), non-sustained VT on 128 
Holter monitoring (1 subject) and pre-operative assessment in valvular disease (1 subject). 129 
Four subjects underwent functional testing for ischemia (either stress echocardiography, 130 
myocardial perfusion scintigraphy, or exercise treadmill testing), which was positive in 3 131 
cases. Ten subjects had all three coronary arteries smooth and unobstructed; the 11th subject 132 
had minor irregularities (<10% stenosis) in all arteries. None of the subjects developed 133 
nNOS and coronary flow during mental stress 
adverse reactions, symptoms or ECG changes of ischemia during the infusions or mental 134 
stress. 135 
 136 
Effect of mental stress and SMTC on coronary flow 137 
The hemodynamic responses and changes in coronary blood flow and coronary conductance 138 
following mental stress are shown in Table 2. The changes in heart rate and blood pressure 139 
during mental stress were minimal, and similar with or without SMTC.  140 
Mental stress increased coronary flow by 34±7.0% (p<0.01) (Figure 2A). SMTC 141 
reduced basal coronary flow by 20±4.7% (p=0.01), consistent with previous work (32, 33). It 142 
also significantly attenuated the vasodilator effect of mental stress, reducing the coronary 143 
flow response to a 26±7.0% increase, compared to the preceding baseline (Figure 2B).  144 
Substance P increased basal coronary flow by 24±8.0% (p=0.01). There was no 145 
significant correlation between the response to substance P and that to mental stress (r2 = -146 
0.22, p=0.83). ISDN increased coronary flow in all subjects (mean increase of 119±40%) 147 
indicating an intact smooth muscle response to NO. 148 
 149 
Effect of mental stress and SMTC on epicardial coronary diameter 150 
Mental stress increased coronary artery diameter by 6.9±3.7% (p=0.02, Figure 3). SMTC 151 
reduced coronary artery diameter by 5.1±1.6% (p<0.01), and abolished the mental stress-152 
induced increase to 0.5±2.8% (p=0.98 compared to preceding baseline). ISDN increased 153 
diameter by 3.9±2.0% (p=0.01) and substance P increased it by 3.1±1.6% (p=0.07). There 154 
was no significant correlation between the % change in coronary diameter and % change in 155 






NO plays an important role in the regulation of vasomotor tone in the human 160 
coronary circulation, both during resting conditions and under situations of increased 161 
metabolic demand. At rest, it maintains a state of tonic vasodilation in resistance vessels (21)  162 
and conduit epicardial arteries (22). Following stimuli such as mental stress and cold pressors 163 
(3, 9, 13, 26), NO mediates dynamic changes in vascular tone that antagonize catecholamine-164 
mediated vasoconstriction. 165 
Until relatively recently, investigations of the role of NO in regulating coronary 166 
vascular tone in humans relied mainly on the use of the non-selective NOS inhibitor L-NG-167 
monomethyl arginine (L-NMMA) or of endothelium-dependent agonists such as 168 
acetylcholine, substance P and fluid shear stress (14, 21, 36-38). Based on such studies, eNOS 169 
expressed in the endothelium was assumed to be the main source of local NO that regulated 170 
vascular tone. However, experimental animal studies indicate that nNOS expressed in 171 
perivascular nerves or the vascular smooth muscle might also regulate local vessel tone (25). 172 
In line with this, nNOS is reported to be expressed in human coronary artery smooth muscle 173 
cells (18) and coronary perivascular nerves in rats and dogs (34, 44).  174 
In first-in-man studies with the nNOS-selective inhibitor, SMTC, we previously 175 
demonstrated that basal blood flow in the human coronary circulation in vivo is under tonic 176 
regulation by local nNOS-derived NO (32). In these studies, we found that SMTC had no 177 
effect on endothelium-dependent vasodilation induced by substance P, which was however 178 
inhibited by L-NMMA. Similarly, local SMTC infusion into the forearm circulation of 179 
healthy human subjects reduced basal blood flow in an L-arginine-dependent manner but 180 
without affecting the vasodilator response to acetylcholine (33). Furthermore, we found that 181 
mental stress-induced increases in forearm blood flow in healthy men were significantly 182 
blunted by local intra-arterial infusion of SMTC, suggesting that local nNOS was involved in 183 
this setting. Previous work in animals has shown that nNOS-dependent effects on vessel tone 184 
vary significantly by vascular bed (10, 19, 23) and so it was important to establish whether 185 
nNOS is involved in mental stress-induced vasodilatation in the human coronary circulation. 186 
nNOS and coronary flow during mental stress 
The novel finding of this study is that nNOS is responsible for mediating mental 187 
stress-induced vasodilation in the resistance vasculature of the human coronary circulation. 188 
The changes in coronary flow and conductance were not related to significant changes in 189 
systemic hemodynamics, suggesting that they represented a direct vasodilator action of 190 
nNOS-derived NO and not effects secondary to altered myocardial oxygen demand. This role 191 
of nNOS contrasts to pacing-induced increases in coronary blood flow, which we recently 192 
reported were mediated by eNOS-derived NO (35). The activation of eNOS during pacing is 193 
likely to involve increased endothelial shear stress whereas nNOS activation during mental 194 
stress may involve perivascular nitrergic nerves in the coronary vessel wall and their 195 
autonomic activation (2, 5). 196 
The baseline response to mental stress in the current study was variable, ranging from 197 
a 1 to 77% increase in blood flow, similar to our previous observations in the forearm. 198 
Previous studies on mental stress-induced vasodilation in humans have reported average 199 
increases ranging from a 55% increase in blood flow (9) to a 10% increase in flow (43), 200 
which may be related to the differing characteristics of study participants. Specific factors that 201 
could have influenced the vascular response to stress in our study include vasoactive 202 
medications, body mass index and diabetes. Local characteristics of the vessel studied could 203 
also have influenced the response, although we selected vessels that were angiographically 204 
free of stenosis. The use of different techniques to elicit mental stress may also contribute to 205 
variation in responses. In the current study, SMTC reduced basal coronary flow as previously 206 
documented (32, 33), and substantially attenuated the mental stress-induced increase in blood 207 
flow. The degree of attenuation in stress-induced vasodilation is similar to that previously 208 
observed in the forearm (20), although it should be noted that subject characteristics were 209 
significantly different between these studies. The current study by necessity was undertaken 210 
in patients undergoing diagnostic coronary angiography and therefore included older patients 211 
with multiple risk factors for coronary disease and on oral medications.  212 
Impaired mental stress-induced increases in flow have been reported in coronary 213 
artery disease (9, 31), metabolic syndrome (8), and non flow-limiting atherosclerosis (43). 214 
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Interestingly, we found little correlation between the response to substance P and the response 215 
to mental stress, suggesting that endothelial eNOS-mediated vasodilator function may not be 216 
the major determinant of the mental stress response. It is possible therefore that the variations 217 
in the mental stress response could in part be explained by the presence of nNOS dysfunction 218 
in these conditions (7, 30, 39). Potential underlying mechanisms include nNOS uncoupling, 219 
which has been documented in conditions of oxidative stress such as atherosclerosis, and 220 
increased levels of the endogenous NOS inhibitor asymmetric dimethylarginine (ADMA), 221 
which has been observed in conditions such as diabetes and hypertension (29).  222 
Numerous studies have been performed to explore the impact of stress on patients 223 
with coronary artery disease, and a recent meta-analysis found that mental stress-induced 224 
ischemia is associated with an approximately doubled risk of cardiac events (myocardial 225 
infarction, revascularization and unstable angina) and total mortality (42). The finding of 226 
reduced coronary blood flow during mental stress has also been shown to be a predictor of 227 
daily ischemia in patients with coronary artery disease, independent of exercise-induced 228 
ischemia (4).  229 
Little is known about the long-term outcomes associated with impaired mental stress-230 
induced vasodilation in people who have been diagnosed with “normal coronary arteries”. 231 
There are some important considerations to bear in mind. Firstly, it is now established that 232 
coronary angiography can underestimate the degree of plaque burden compared to 233 
postmortem histology (40). Secondly, a degree of “visual-functional” mismatch occurs on 234 
coronary angiography, which can under or over- estimate a plaque’s functional severity in up 235 
to 40% of cases (28). Thirdly, it is increasingly understood that the majority of acute coronary 236 
syndromes arise from plaques that are not necessarily flow-limiting in size but share 237 
vulnerable characteristics that ultimately lead to their rupture (6). Indeed, Yeung et al found 238 
that mental stress triggers vasoconstriction at the site of both obstructive and non-obstructive 239 
plaques in epicardial arteries, with an accompanying decrease in myocardial blood flow (43). 240 
Additionally, Arrighi et al found that mental stress caused increased coronary resistance and 241 
impaired myocardial blood flow in regions subtended by vessels without significant stenosis 242 
nNOS and coronary flow during mental stress 
(1). In the current study, we observed nNOS-dependent changes in epicardial coronary artery 243 
diameter as well as coronary blood flow in response to acute mental stress. These effects were 244 
not correlated with each other, suggesting that they may both reflect direct effects of nNOS, 245 
but we cannot exclude the possibility that the changes in epicardial diameter might be 246 
secondary to the changes in blood flow. Given the identification of nNOS as a mediator of 247 
stress-induced coronary flow in individuals with angiographically normal arteries, it would be 248 
of interest to examine its function in patients with established coronary disease.  249 
In conclusion, this study identifies nNOS as the major NOS isoform responsible for 250 
mediating the vasodilator response to mental stress in the human coronary circulation. Due to 251 
the complex interplay that exists between mental stress and vasodilator function in the 252 
coronary circulation, dysfunctional blood flow responses to mental stress may contribute to 253 
the development of stress-induced myocardial ischemia, irrespective of the presence of 254 
angiographically significant coronary artery disease. 255 
 256 
Study limitations 257 
We estimated coronary blood flow from flow velocity rather than using 258 
thermodilution, but flow velocity has been widely used in studies of coronary vascular 259 
function. All the participants in our study either had risk factors for vascular endothelial 260 
dysfunction and/or were on vasoactive medications, so that the current results do not 261 
necessarily reflect the role of nNOS in completely healthy humans. To minimize potential 262 
confounding effects of these factors, we studied arteries that appeared angiographically 263 
smooth and unobstructed and we omitted medications on the day of the study.  In addition, 264 
the impact of co-existing atherosclerosis risk factors in this study was not sufficient to impair 265 
endothelium-dependent vasodilation to substance P. 266 
 267 
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FIGURE LEGENDS 435 
 436 
Figure 1. Schematic representation of the infusion protocol. Average peak velocity, 437 
coronary angiography, BP, heart rate and ECG were recorded at each stage. ISDN, Isosorbide 438 
dinitrate; SMTC, S-methyl L-thiocitrulline. 439 
 440 
Figure 2. Effect of S-methyl L-thiocitrulline (SMTC) on mental stress-induced increase 441 
in coronary blood flow (CBF). A, % change in CBF with the Stroop test during saline 442 
infusion (Stroop), SMTC, and the Stroop test during SMTC infusion. n=11, paired t-test 443 
between CBF during preceding baseline and intervention. * p<0.01 compared to 444 
preceding baseline. B, Absolute values for CBF under the different study conditions. n=11;  445 
*, significant interaction between groups by repeated measures ANOVA. 446 
 447 
 448 
Figure 3. Changes in epicardial coronary artery diameter in response to interventions. 449 
Percentage changes from the preceding baseline are shown. Sub P, substance P; ISDN, 450 
nNOS and coronary flow during mental stress 
isosorbide dinitrate; Stroop, mental stress test; SMTC, S-methyl l-thiocitrulline. n=11, paired 451 
t test between diameter during preceding baseline and intervention. *, p<0.05 cf. 452 
preceding baseline. 453 
  454 
17 
 
Table 1. Baseline characteristics of patients. Data are presented as mean ± SD. 455 
 456 
Characteristic 457 
n    11 458 
Age (years)   58±14 459 
Sex (M/F)   6/5 460 
Hypertension, n  7 461 
Diabetes mellitus, n  2 462 
Hypercholesterolaemia, n 8 463 
Smoker, n   0 464 
BMI (kg/m
2
)   28.2±3.2 465 
Medication: n (%) 466 
ACEI/ARB  4 (36) 467 
β blockers or CCB 5 (45) 468 
Statins   2 (18) 469 
Study artery, n 470 
LAD   7 471 
Cx   3 472 
RCA   1 473 
 474 
  475 
nNOS and coronary flow during mental stress 
Table 2. Hemodynamic Responses During Mental Stress +/- SMTC 476 
 477 
 478 
     Saline    SMTC 479 




Heart rate (bpm)  59±3.7  60±3.9  55±3.0  62±4.9  484 
 485 
Systolic BP (mmHg)  117±3.7 120±6.0 114±4.0 119±5.4486 
  487 
Mean BP (mmHg)  84±1.4  83±2.7  81±3.0  84±3.5  488 
 489 
Diastolic BP (mmHg)  68±2.3  64±2.5  65±3.9  67±4.3 490 
  491 
Coronary blood flow 492 
(ml/min)   38±3.9  52±5.4** 31±4.0  40±4.5**#493 
   494 
Coronary conductance 495 
(units)    0.49±0.04 0.61±0.08* 0.42±0.06         0.53±0.05*#496 
  497 
 498 
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